Dr. Stout joined Immunomedics in 2019 after serving as a consultant for 9 months. Dr. Stout has over 30 years of biopharmaceutical development and large scale biologics manufacturing experience. Prior to joining Immunomedics, Dr. Stout was Sr Vice President of Technical Operations at Versartis working on long acting growth hormones. Prior to Versartis, Dr. Stout held positions of increasing responsibility at biopharmaceutical companies including Merck, Amgen, Pfizer, and BioNebraska (Restoragen). Dr. Stout has been involved in the launch and buildout of networks to support blockbuster products Keytruda and Enbrel. Dr. Stout has been involved in the scale up, technology transfer, and licensure of more than ten biologics products in more than twenty manufacturing facilities. Dr. Stout has a Ph.D. in Chemistry and Biochemistry from the University of Nebraska-Lincoln and M.S. and B.S. in Chemistry from the University of Iowa.